Orasure Technologies (OSUR) Net Income towards Common Stockholders (2010 - 2025)
Orasure Technologies (OSUR) reported Net Income towards Common Stockholders of -$13.3 million for Q3 2025, down 240.43% on a YoY basis from $9.5 million in Q3 2024, and up 29.39% sequentially from -$18.9 million in Q2 2025.
Orasure Technologies (OSUR) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Orasure Technologies (OSUR) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$13.3 million in Q3 2025.
- For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 240.43% year-over-year to -$13.3 million; the trailing twelve-month figure through Dec 2025 stood at -$47.7 million (down 167.04% YoY), and the FY2024 full-year result was -$17.8 million, down 133.17% from the prior year.
- Net Income towards Common Stockholders improved to -$13.3 million in Q3 2025, from -$18.9 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $27.2 million in Q1 2023 to a low of -$19.9 million in Q1 2022.
- A 5-year average of -$2.7 million and a median of -$3.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders jumped 252.04% in 2022 and sank 34247.27% in 2025, its largest moves.
- Tracing OSUR's Net Income towards Common Stockholders over 5 years: stood at -$10.4 million in 2021, then jumped by 252.04% to $15.8 million in 2022, then climbed by 27.04% to $20.1 million in 2023, then plunged by 151.34% to -$10.3 million in 2024, then dropped by 29.42% to -$13.3 million in 2025.
- Business Quant data shows OSUR's Net Income towards Common Stockholders at -$13.3 million in Q3 2025, -$18.9 million in Q2 2025, and -$15.5 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Orasure Technologies | 289.46 Mn | 90.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.34 Mn |
| Jun 30, 2025 | -18.89 Mn |
| Mar 31, 2025 | -15.47 Mn |
| Dec 31, 2024 | -10.31 Mn |
| Sep 30, 2024 | -3.92 Mn |
| Jun 30, 2024 | -55,000.00 |
| Mar 31, 2024 | -3.58 Mn |
| Dec 31, 2023 | 20.07 Mn |
| Sep 30, 2023 | 11.21 Mn |
| Jun 30, 2023 | -4.76 Mn |
| Mar 31, 2023 | 27.22 Mn |
| Dec 31, 2022 | 15.80 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | -18.59 Mn |
| Mar 31, 2022 | -19.94 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | -15.02 Mn |
| Jun 30, 2021 | -1.36 Mn |
| Mar 31, 2021 | 3.77 Mn |
| Dec 31, 2020 | 49.07 Mn |